Notícias

This fintech stock trades 45% below its record high reached in November 2025.

Coherent just handed back a third of its value in three months without a single crack in its operating story, and Wall Street is responding by piling on price target upgrades instead of downgrades. Something about this setup does not add up, and the answer changes how you read every AI optics name right now.

Many boomers may have missed the bus. Don’t make the same mistake.

A federal judge rejected the DOJ's push to force Google to sell AdX, the same day Alphabet unveiled its third Flash AI model in six weeks

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.

The fiber optic gear maker's fiscal Q3 earnings boomed 215%. Revenue and sales guidance slightly topped. Shares rose.

Microsoft says it will reorganize its reporting structure from three segments into two: Agents and Infra, and Devices and Consumer.

Founder Group Limited has announced that its subsidiary, Founder Energy Sdn. Bhd., is actively participating in Malaysia’s largest-ever utility-scale solar initiative, the Large-Scale Solar 6 (LSS6) programme. Launched by the Ministry of Energy Transition and Water Transformation (PETRA) in July 2026, LSS6 aims to introduce 2,500 megawatts (MW) of solar capacity paired with 1,250MW of battery energy storage, further investing between RM13 and RM15 billion (approximately US$3.2 billion to...

TJX said its $331 million reimbursement was partially offset by supply chain investments, while Burlington's $55 million return will be used to boost customer value.

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.

Stock futures fall, Broadcom beat forecasts for AI Chip sales growth, Micron and China chip makers fight for market share.

Selling online can come with an unexpected catch: Marketplaces may hold your money long after a buyer has paid, leaving sellers waiting on their cash.

Jim Cramer says Snowflake stock faces a huge move after a 23% pop, while Broadcom's AI beat gets a cooler read.

Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who lost money in tech stocks during 2022.

Stock index futures wavered Thursday morning after major indexes snapped three-day losing streaks in the prior session

Two timely investments over the last year have significantly appreciated in value.

Wall Street futures were mixed pre-bell Thursday, as interest rates eased marginally but global crud

These two chip stocks have different businesses entirely.

Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who lost money in tech stocks during 2022.

It’s taken Tesla a while, but it finally looks ready to dispense with the steering wheel. The electric-vehicle maker is set to host a Cybercab event in Austin, Texas, this evening. Cybercab, Tesla’s purpose-built robo-taxi without pedals or a steering wheel that went into mass production earlier this year, is the culmination of years of work on autonomous driving technology.

The company is moving from three segments to two, and will disclose Azure cloud revenue on a quarterly basis for the first time

Tesla's bull case and bear case are both stronger than usual right now, and that tension is exactly what makes the stock so difficult to read at current levels.

Microsoft stock looks cheap at current levels.

Initially dropping after a mixed earnings report, Apple stock charges toward a breakout as it gets ready to "Surprise and shine."

Britain’s first self-driving taxis have finally arrived. After years of testing and development, Uber and British AI company Wayve started offering autonomous rides to the public on Thursday.

The facility, which is planned to support Google’s data centres in the area, will combine solar and advanced energy storage.

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.

Innodata (INOD) recently reported a 58% year over year revenue surge and reaffirmed its 2026 revenue growth outlook of at least 40%, highlighting management’s confidence in the company’s AI focused data engineering model. Despite the strong revenue update, Innodata’s share price has been under pressure recently, with the stock down 14.18% over the past month and 55.32% over the past 90 days. This comes even as the 1 year total shareholder return sits at 48.01% and the 5 year total shareholder...

Ford Motor (F) has drawn fresh attention after naming Dave Carroll as president of Ford Energy following Lisa Drake’s retirement announcement. The leadership change gives investors new context for assessing the stock. Ford Motor’s share price has moved higher over the past week, with a 1-day share price return of 2.17% and a 7-day share price return of 1.73%. It is still down 7.82% over 90 days, while the 1-year total shareholder return of 27.36% points to momentum that has been building over...

Biogen (NasdaqGS: BIIB) and Eisai launched LEQEMBI IQLIK, a once-weekly subcutaneous injection for early Alzheimer's disease, now available in the U.S. for initiation and maintenance therapy. The treatment allows at-home dosing for eligible patients using a pre-filled syringe or autoinjector, following a step-up initiation schedule. LEQEMBI IQLIK is described as the first anti-amyloid therapy with an approved subcutaneous initiation option that can be started outside an infusion...